View Older Stories View More Recent Stories

Apr 20, 2026 10:21AM Nektar Therapeutics (NKTR) PT Raised to $178 at BTIG
Apr 20, 2026 09:48AM Jefferies stays Buy on Nektar Therapeutics (NKTR) after Rezpeg data hits upside estimates, sees 10-30% stock move into Ph3
Apr 20, 2026 08:23AM Oppenheimer Reiterates Outperform Rating on Nektar Therapeutics (NKTR)
Apr 20, 2026 07:43AM Nektar Therapeutics reports positive 52-week data for alopecia areata drug trial
Apr 20, 2026 07:30AM Nektar Therapeutics (NKTR) Halted, News Pending
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 7, 2026 08:36AM Citi Adds Nektar Therapeutics (NKTR) to 30-Day Upside Catalyst Watch List
Apr 1, 2026 09:57AM Oppenheimer on Nektar Therapeutics (NKTR): 'meaningful opportunities for biologics in AA'
Mar 24, 2026 06:53AM Wedbush Starts Nektar Therapeutics (NKTR) at Neutral
Mar 17, 2026 05:30AM TD Cowen Starts Nektar Therapeutics (NKTR) at Buy
Mar 13, 2026 12:39PM Nektar Therapeutics (NKTR) PT Raised to $140 at Oppenheimer
Mar 12, 2026 04:36PM Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Mar 9, 2026 07:10AM Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Nektar Therapeutics, (NKTR)
Feb 10, 2026 12:11PM Nektar Therapeutics (NKTR) PT Raised to $151 at BTIG
Feb 10, 2026 11:27AM William Blair Upgrades Nektar Therapeutics (NKTR) to Outperform
Feb 10, 2026 07:01AM Nektar reports positive REZOLVE-AD maintenance data for atopic dermatitis drug
Jan 26, 2026 08:56AM Piper Sandler on Nektar Therapeutics (NKTR): 'We See a Substantial Opportunity Into These De-Risked Data'
Dec 17, 2025 06:47AM Nektar Therapeutics (NKTR) PT Raised to $135 at H.C. Wainwright
Dec 17, 2025 04:31AM Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Dec 16, 2025 11:04AM Nektar Therapeutics (NKTR) PT Raised to $115 at Oppenheimer
Dec 16, 2025 07:30AM Nektar reports mixed phase 2b results for alopecia areata drug
Dec 16, 2025 07:25AM Nektar Therapeutics (NKTR) Halted, News Pending
Nov 24, 2025 05:35AM Nektar Therapeutics (NKTR) PT Raised to $121 at Jefferies
Nov 12, 2025 04:34PM Nektar Therapeutics enters $110 million equity distribution agreement
Nov 10, 2025 03:05AM Oppenheimer Reiterates Outperform Rating on Nektar Therapeutics (NKTR)
Nov 6, 2025 05:15PM Nektar Therapeutics (NKTR) Tops Q3 EPS by 185c
Oct 24, 2025 09:52AM Nektar Therapeutics (NKTR) on Watch Following M&A Chatter
Oct 17, 2025 02:05PM Nektar Therapeutics (NKTR) PT Raised to $105 at B.Riley
Oct 17, 2025 01:32PM Nektar Therapeutics (NKTR) Strength Attributed to Rumor
Sep 18, 2025 03:48PM Nektar Therapeutics (NKTR) PT Raised to $99 at Jefferies
Sep 18, 2025 08:46AM Nektar presents positive Phase 2b atopic dermatitis trial results
Sep 15, 2025 08:32AM Piper Sandler on Nektar Therapeutics (NKTR): 'A Perfect Opportunity to Own NKTR Ahead of Additional AD Data'
Sep 4, 2025 03:39PM Analysts postive on Nektar opportunity after Sanofi data
Aug 7, 2025 04:29PM Nektar Therapeutics (NKTR) Misses Q2 EPS by 258c
Jul 29, 2025 09:01AM Nektar receives FDA fast track for alopecia areata treatment
Jul 1, 2025 07:18AM Nektar Therapeutics (NKTR) Prices 4.26M Share Offering at $23.50/sh
Jun 30, 2025 04:03PM Nektar Therapeutics (NKTR) Announces Proposed Public Offering
Jun 25, 2025 03:20PM Nektar Therapeutics (NKTR) call put ratio 1 call to 1 put on 15K contracts as share price up 24%
Jun 25, 2025 06:39AM Nektar Therapeutics (NKTR) PT Raised to $120 at H.C. Wainwright
Jun 25, 2025 04:56AM Increasing unusual option volume: NKTR RGLS PAGS ASTL NTS HUYA PAYX EWY
Jun 24, 2025 03:41PM Nektar Therapeutics (NKTR) PT Raised to $69 at Jefferies, 'data update gives us further confidence in Rezpeg's potential'
Jun 24, 2025 01:11PM Nektar Therapeutics (NKTR) PT Raised to $100 at BTIG, 'We see NKTR as a "pound the table BUY"'
Jun 24, 2025 10:45AM Increasing unusual option volume: NKTR PAGS GXO SFIX HUYA NTS RZLV MAIN COTY
Jun 24, 2025 07:40AM Nektar Therapeutics (NKTR) to Resume Trading at 8 am
Jun 24, 2025 07:31AM Nektar Therapeutics (NKTR): REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe AD
Jun 24, 2025 07:00AM Nektar Therapeutics (NKTR) Halted, News Pending
Jun 23, 2025 04:31PM Nektar Therapeutics (NKTR) to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June
May 12, 2025 07:03AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)
May 9, 2025 05:30AM BTIG Reiterates Buy Rating on Nektar Therapeutics (NKTR)
May 8, 2025 04:43PM Nektar Therapeutics (NKTR) Misses Q1 EPS by 8c
View More Recent Stories View Older Stories